Summary

The global H. pylori Stool Antigen Tests market is projected to grow from US$ 168 million in 2025 to US$ 267 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
H. pylori Stool Antigen Tests are in vitro diagnostic products designed to detect Helicobacter pylori antigens in human stool specimens for non-invasive identification of active H. pylori infection and, where supported by product labeling and clinical practice, confirmation of eradication after therapy. Commercial products are available as visual rapid-test cassettes, reader-assisted cassettes, microplate kits, and dedicated reagents for automated immunoassay analyzers. The principal technology routes include lateral flow immunochromatography, fluorescence immunoassay, enzyme immunoassay, chemiluminescence immunoassay, and latex turbidimetric immunoassay. Product outputs range from qualitative positive or negative interpretation to quantitative-capable measurements on instrument-based platforms. H. pylori Stool Antigen Tests are used across hospital laboratories, hospital point-of-care settings, gastroenterology clinics, primary-care facilities, independent reference laboratories, and selected home self-testing channels, forming a diagnostic category that combines decentralized rapid testing with centralized laboratory immunoassay workflows. Current commercial products also support both initial active-infection assessment and post-treatment confirmation of antigen clearance.
Key Findings
Lateral flow immunochromatography remains the principal volume technology in the global product mix
Professional medical testing remains the dominant use setting while regulated home self-testing is expanding
Market Trends
The H. pylori Stool Antigen Tests market is evolving from a product structure dominated by visually interpreted rapid tests toward a broader combination of rapid testing, reader-assisted assays, and automated laboratory immunoassays. Lateral flow cassettes retain a strong position because they offer short turnaround time, relatively simple sample preparation, limited equipment requirements, and broad suitability for decentralized testing. At the same time, fluorescence immunoassay and other reader-based formats are gaining relevance in facilities seeking objective interpretation and standardized workflows, while microplate enzyme immunoassays and automated reagent systems continue to serve higher-throughput laboratories. Commercial product portfolios already demonstrate this coexistence of one-step lateral flow, quantitative-capable EIA, and instrument-oriented testing. Product development is increasingly focused on reducing hands-on time, improving stool-sample handling, supporting objective result interpretation, and extending testing into smaller clinics and selected home-use settings. The longer-term direction is therefore not replacement of one technology by another, but segmentation between high-volume rapid testing and higher-value laboratory or reader-based solutions.
Market Dynamics
Drivers
Demand is supported by the large global burden of H. pylori infection and by the clinical need to identify active infection through non-invasive methods. Stool antigen testing can be deployed without endoscopy and is suitable for both decentralized and laboratory-based workflows, supporting use across primary care, gastroenterology, hospitals, and reference laboratories. A further recurring demand layer is created by eradication confirmation: the 2024 American College of Gastroenterology guideline recommends test-of-cure assessment at least four weeks after therapy and identifies fecal antigen testing as one of the recommended methods. This creates a structural pathway in which some patients generate both initial-diagnosis and post-treatment testing demand. Expansion of POCT infrastructure, greater availability of rapid immunochromatographic products, and broader access to standardized diagnostic kits in emerging markets also support test-volume growth.
Restraints
The market faces substitution pressure from urea breath testing, biopsy-based testing, and molecular diagnostic methods, while local clinical practice patterns differ significantly across countries. Stool collection and specimen preparation remain less convenient for some patients than breath-based testing, particularly in outpatient and consumer settings. Test timing also matters: acid suppression, antibiotics, and bismuth-containing therapy can increase the risk of false-negative results when testing is performed too soon after treatment, which requires disciplined clinical workflows. Instrument-based fluorescence, enzyme immunoassay, chemiluminescence, and automated turbidimetric solutions additionally require analyzer infrastructure or laboratory capacity, limiting penetration in low-throughput settings. In the rapid-test segment, high manufacturing capacity among Asian suppliers and extensive OEM competition continue to constrain manufacturer-level price expansion despite product upgrades.
Opportunities
The most attractive opportunities are concentrated in decentralized active-infection testing, structured eradication confirmation, reader-assisted rapid diagnostics, laboratory automation, and regulated home self-testing. Rapid stool antigen products can extend H. pylori testing into clinics that lack breath-analysis equipment or advanced laboratory infrastructure, while reader-based assays can improve interpretation consistency in decentralized professional settings. Automated and quantitative-capable products create additional opportunities in hospital and reference laboratories where throughput, reproducibility, and workflow integration are important. Manufacturers with strong lateral-flow production capability can also expand internationally through OEM and private-label channels, particularly in fragmented markets where local distributors and brands remain important. Home-use products provide an additional route to market where regulatory authorization and clear referral pathways are established, although this channel remains complementary to professional testing rather than a replacement for it.
Challenges
Long-term competition is shaped by differences in assay performance, antibody systems, sample-preparation methods, regulatory requirements, and manufacturing quality. The category contains multinational diagnostic groups, specialized immunodiagnostic manufacturers, regional rapid-test companies, and large OEM producers, which creates significant pricing and channel fragmentation. Maintaining lot-to-lot consistency is particularly important because stool matrices are heterogeneous and rapid assays rely heavily on extraction quality, membrane performance, and antibody specificity. Different regulatory pathways for professional-use and self-test products also make simultaneous global commercialization difficult. Another challenge is identifying the true competitive structure because a single manufacturing group may supply several regional brands or operate through multiple subsidiaries, making group-level consolidation necessary when assessing supplier concentration.
Industry Chain Analysis
The upstream segment includes monoclonal and polyclonal antibodies, nitrocellulose membranes, conjugate pads, absorbent materials, colloidal and latex particles, fluorescent labels, enzymes, substrates, buffers, microplates, plastic cassettes, stool collection components, calibrators, controls, and packaging materials. Antibody affinity and specificity, membrane consistency, extraction-buffer formulation, conjugate stability, and reagent shelf life directly affect diagnostic performance and manufacturing yield. Instrument-based H. pylori Stool Antigen Tests additionally require analyzer-compatible reagent containers, optical or fluorescent labels, calibration systems, and dedicated consumables, creating a more integrated upstream supply structure than conventional visual lateral-flow products.
The midstream segment covers assay development, biological raw-material preparation, coating and conjugation, strip lamination, cassette assembly, reagent filling, calibration, quality control, packaging, regulatory registration, and commercial manufacturing. Lateral-flow producers create value primarily through manufacturing scale, yield control, product consistency, low unit cost, regulatory coverage, and distribution efficiency. Instrument-platform suppliers capture additional value through proprietary reagents, analyzer compatibility, software-assisted interpretation, and recurring consumable demand. Downstream demand comes from hospital central laboratories, hospital point-of-care departments, gastroenterology and primary-care clinics, independent reference laboratories, distributors, and regulated home-testing channels. This places H. pylori Stool Antigen Tests in the midstream IVD reagent and POCT manufacturing segment of the broader medical-device industry chain.
Segment Insights
By detection technology, lateral flow immunochromatography represents the broadest commercial product base and remains the principal shipment-volume segment. Commercial products are commonly configured as single-step or short-procedure cassettes for qualitative antigen detection in stool, with several leading suppliers offering test times around ten minutes and multi-test professional packages. Fluorescence immunoassay occupies a more instrument-dependent position and is suited to facilities that require rapid turnaround combined with objective reader interpretation. Enzyme immunoassay remains relevant for batch laboratory testing, with established products supplied in 96-well formats and, in some cases, supporting both qualitative and quantitative analysis. Chemiluminescence and latex turbidimetric immunoassays are concentrated in automated laboratory settings, while less widely adopted technologies are grouped into the Other category.
By operating format, the market can be divided into visual cassettes, reader-assisted cassettes, microplate kits, automated analyzer reagents, and Other products. Visual cassettes dominate decentralized testing because of their low equipment requirement, while reader-assisted formats provide more standardized interpretation. Microplate kits support batch processing, and automated analyzer reagents target larger laboratories seeking higher throughput and workflow integration. By result capability, qualitative-only products account for most rapid-test consumption, whereas quantitative-capable products are more concentrated in instrument-based systems. This product structure creates two distinct competitive models: high-volume rapid tests driven by cost, manufacturing scale, and channel reach, and higher-value instrument-based assays driven by automation, reproducibility, and recurring reagent consumption.
Downstream Market Opportunities
By clinical purpose, the two core application pathways are active-infection diagnosis and eradication confirmation. Active-infection testing generates demand from patients presenting with dyspeptic symptoms, ulcer-related conditions, or other clinical indications for H. pylori assessment, while post-treatment confirmation creates recurring demand after eradication therapy. Professional guidelines supporting test-of-cure reinforce the role of stool antigen testing in this second application pathway.
By end-use setting, primary-care and gastroenterology clinics favor rapid and easy-to-operate formats, while hospital central laboratories and independent reference laboratories support batch and automated immunoassays. Hospital point-of-care environments provide an intermediate opportunity for reader-assisted and fluorescence-based products where same-visit decision-making and objective interpretation are valuable. Home self-testing represents an emerging incremental channel in selected regulated markets, supported by single-test packaging and simplified procedures, but professional medical testing remains the dominant utilization setting because diagnosis, treatment selection, and eradication follow-up generally require integration with clinical care.
Regional Insights
North America and Europe are mature, higher-value diagnostic markets characterized by established clinical pathways, strong regulatory oversight, specialist IVD suppliers, and meaningful use of both branded rapid assays and laboratory immunoassay systems. The United States supports established stool antigen products for both active-infection diagnosis and post-treatment confirmation, while European suppliers maintain broad portfolios spanning lateral flow, EIA, reader-based, and automated technologies. Japan and South Korea have strong domestic diagnostic manufacturing capabilities and support a mix of proprietary rapid-test and instrument-based immunoassay platforms.
China is one of the most important manufacturing and export supply bases for H. pylori Stool Antigen Tests, supported by large-scale rapid-test production, extensive OEM capability, broad domestic IVD distribution, and a growing portfolio of professional and self-test products. China Taiwan also hosts specialized rapid-test manufacturers with international and private-label business. India has a sizable base of regional IVD producers and remains strongly price-sensitive, while Southeast Asia depends more heavily on imported products and local distribution networks. Israel and Türkiye contribute specialized regional manufacturers, and Latin America remains a mixed market in which imported rapid tests coexist with a more limited local manufacturing base.
Competitive Landscape Analysis
The competitive landscape is fragmented and combines multinational diagnostic groups, large-scale rapid-test manufacturers, specialist immunodiagnostic companies, and regional IVD producers. Group consolidation is important when assessing actual competitive concentration. SSI Diagnostica operates as one group incorporating portfolios such as TECHLAB and CTK Biotech, while Meridian Bioscience has been owned through the SD Biosensor and SJL Partners consortium since completion of the 2023 transaction; Meridian continues to operate as an independent entity under that ownership. Large-scale suppliers such as Abbott Laboratories, SD Biosensor, SSI Diagnostica, ACON Laboratories, Guangzhou Wondfo Biotech, Zhejiang Orient Gene Biotech, HANGZHOU ALLTEST BIOTECH, R-Biopharm, Denka, Getein Biotech, and Sentinel Diagnostics compete through combinations of production scale, technology breadth, registration coverage, OEM capability, and international distribution. Mid-sized companies including Boditech Med, Certest Biotec, MIZUHO MEDY, Wakamoto Pharmaceutical, Humasis, Innovita Biological Technology, Assure Tech, Trinity Biotech, Savyon Diagnostics, nal von minden, DIALAB, Biopanda, Apacor, Panion & BF Biotech, STRONG BIOTECH, Lepu Diagnostics, and Cofoe Medical compete through regional distribution, specialized assay formats, flexible product positioning, and targeted technology platforms. No single competitive model dominates across rapid testing, laboratory automation, OEM supply, and home-use channels.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global H. pylori Stool Antigen Tests market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Abbott Laboratories
SD Biosensor, Inc.
SSI Diagnostica A/S
ACON Laboratories, Inc.
Guangzhou Wondfo Biotech Co., Ltd.
Zhejiang Orient Gene Biotech Co., Ltd.
HANGZHOU ALLTEST BIOTECH CO., LTD.
R-Biopharm AG
Denka Company Limited
Autobio Diagnostics Co., Ltd.
Getein Biotech, Inc.
Sentinel Diagnostics
Boditech Med Inc.
Certest Biotec, S.L.
MIZUHO MEDY Co., Ltd.
Wakamoto Pharmaceutical Co., Ltd.
Humasis Co., Ltd.
Innovita Biological Technology Co., Ltd.
Assure Tech Hangzhou Co., Ltd.
Trinity Biotech plc
Savyon Diagnostics Ltd.
nal von minden GmbH
DIALAB GmbH
Biopanda Reagents Ltd.
Apacor Limited
Panion & BF Biotech, Inc.
STRONG BIOTECH CORPORATION
Beijing Lepu Diagnostics Technology Co., Ltd.
Cofoe Medical Technology Co., Ltd.
Segment by Type
Lateral Flow Immunochromatography
Fluorescence Immunoassay
Enzyme Immunoassay
Chemiluminescence Immunoassay
Latex Turbidimetric Immunoassay
Other
Segment by Operating Format
Visual Cassette
Reader Assisted Cassette
Microplate Kit
Automated Analyzer Reagent
Other
Segment by Application
Home Self-Testing
Primary Care Clinic Testing
Gastroenterology Clinic Testing
Hospital Point-of-Care Testing
Hospital Central Laboratory Testing
Independent Reference Laboratory Testing
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the H. pylori Stool Antigen Tests study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to H. pylori Stool Antigen Tests: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global H. pylori Stool Antigen Tests Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Lateral Flow Immunochromatography
1.2.3 Fluorescence Immunoassay
1.2.4 Enzyme Immunoassay
1.2.5 Chemiluminescence Immunoassay
1.2.6 Latex Turbidimetric Immunoassay
1.2.7 Other
1.3 Market Segmentation by Operating Format
1.3.1 Global H. pylori Stool Antigen Tests Market Size by Operating Format, 2021 vs 2025 vs 2032
1.3.2 Visual Cassette
1.3.3 Reader Assisted Cassette
1.3.4 Microplate Kit
1.3.5 Automated Analyzer Reagent
1.3.6 Other
1.4 Market Segmentation by Application
1.4.1 Global H. pylori Stool Antigen Tests Market Size by Application, 2021 vs 2025 vs 2032
1.4.2 Home Self-Testing
1.4.3 Primary Care Clinic Testing
1.4.4 Gastroenterology Clinic Testing
1.4.5 Hospital Point-of-Care Testing
1.4.6 Hospital Central Laboratory Testing
1.4.7 Independent Reference Laboratory Testing
1.4.8 Other
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global H. pylori Stool Antigen Tests Revenue Estimates and Forecasts (2021-2032)
2.2 Global H. pylori Stool Antigen Tests Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global H. pylori Stool Antigen Tests Sales Estimates and Forecasts (2021-2032)
2.4 Global H. pylori Stool Antigen Tests Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global H. pylori Stool Antigen Tests Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global H. pylori Stool Antigen Tests Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Lateral Flow Immunochromatography: Market Share by Key Manufacturers
3.5.2 Fluorescence Immunoassay: Market Share by Key Manufacturers
3.5.3 Enzyme Immunoassay: Market Share by Key Manufacturers
3.5.4 Chemiluminescence Immunoassay: Market Share by Key Manufacturers
3.5.5 Latex Turbidimetric Immunoassay: Market Share by Key Manufacturers
3.5.6 Other: Market Share by Key Manufacturers
3.6 Global H. pylori Stool Antigen Tests Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global H. pylori Stool Antigen Tests Sales Performance by Type
4.1.1 Global H. pylori Stool Antigen Tests Sales Volume by Type (2021-2032)
4.1.2 Global H. pylori Stool Antigen Tests Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global H. pylori Stool Antigen Tests Sales Performance by Operating Format
4.2.1 Global H. pylori Stool Antigen Tests Sales Volume by Operating Format (2021-2032)
4.2.2 Global H. pylori Stool Antigen Tests Revenue by Operating Format (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Operating Format (2021-2032)
4.3 Product Technology Differentiation
4.4 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.4.1 High-Growth Niches and Adoption Drivers
4.4.2 Profitability Hotspots and Cost Drivers
4.4.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global H. pylori Stool Antigen Tests Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global H. pylori Stool Antigen Tests Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America H. pylori Stool Antigen Tests Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America H. pylori Stool Antigen Tests Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe H. pylori Stool Antigen Tests Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe H. pylori Stool Antigen Tests Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific H. pylori Stool Antigen Tests Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific H. pylori Stool Antigen Tests Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America H. pylori Stool Antigen Tests Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America H. pylori Stool Antigen Tests Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa H. pylori Stool Antigen Tests Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa H. pylori Stool Antigen Tests Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.1.4 Abbott Laboratories H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Abbott Laboratories H. pylori Stool Antigen Tests Sales by Product in 2025
11.1.6 Abbott Laboratories H. pylori Stool Antigen Tests Sales by Application in 2025
11.1.7 Abbott Laboratories H. pylori Stool Antigen Tests Sales by Geographic Area in 2025
11.1.8 Abbott Laboratories H. pylori Stool Antigen Tests SWOT Analysis
11.1.9 Abbott Laboratories Recent Developments
11.2 SD Biosensor, Inc.
11.2.1 SD Biosensor, Inc. Corporation Information
11.2.2 SD Biosensor, Inc. Business Overview
11.2.3 SD Biosensor, Inc. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.2.4 SD Biosensor, Inc. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 SD Biosensor, Inc. H. pylori Stool Antigen Tests Sales by Product in 2025
11.2.6 SD Biosensor, Inc. H. pylori Stool Antigen Tests Sales by Application in 2025
11.2.7 SD Biosensor, Inc. H. pylori Stool Antigen Tests Sales by Geographic Area in 2025
11.2.8 SD Biosensor, Inc. H. pylori Stool Antigen Tests SWOT Analysis
11.2.9 SD Biosensor, Inc. Recent Developments
11.3 SSI Diagnostica A/S
11.3.1 SSI Diagnostica A/S Corporation Information
11.3.2 SSI Diagnostica A/S Business Overview
11.3.3 SSI Diagnostica A/S H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.3.4 SSI Diagnostica A/S H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 SSI Diagnostica A/S H. pylori Stool Antigen Tests Sales by Product in 2025
11.3.6 SSI Diagnostica A/S H. pylori Stool Antigen Tests Sales by Application in 2025
11.3.7 SSI Diagnostica A/S H. pylori Stool Antigen Tests Sales by Geographic Area in 2025
11.3.8 SSI Diagnostica A/S H. pylori Stool Antigen Tests SWOT Analysis
11.3.9 SSI Diagnostica A/S Recent Developments
11.4 ACON Laboratories, Inc.
11.4.1 ACON Laboratories, Inc. Corporation Information
11.4.2 ACON Laboratories, Inc. Business Overview
11.4.3 ACON Laboratories, Inc. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.4.4 ACON Laboratories, Inc. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 ACON Laboratories, Inc. H. pylori Stool Antigen Tests Sales by Product in 2025
11.4.6 ACON Laboratories, Inc. H. pylori Stool Antigen Tests Sales by Application in 2025
11.4.7 ACON Laboratories, Inc. H. pylori Stool Antigen Tests Sales by Geographic Area in 2025
11.4.8 ACON Laboratories, Inc. H. pylori Stool Antigen Tests SWOT Analysis
11.4.9 ACON Laboratories, Inc. Recent Developments
11.5 Guangzhou Wondfo Biotech Co., Ltd.
11.5.1 Guangzhou Wondfo Biotech Co., Ltd. Corporation Information
11.5.2 Guangzhou Wondfo Biotech Co., Ltd. Business Overview
11.5.3 Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.5.4 Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests Sales by Product in 2025
11.5.6 Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests Sales by Application in 2025
11.5.7 Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests Sales by Geographic Area in 2025
11.5.8 Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests SWOT Analysis
11.5.9 Guangzhou Wondfo Biotech Co., Ltd. Recent Developments
11.6 Zhejiang Orient Gene Biotech Co., Ltd.
11.6.1 Zhejiang Orient Gene Biotech Co., Ltd. Corporation Information
11.6.2 Zhejiang Orient Gene Biotech Co., Ltd. Business Overview
11.6.3 Zhejiang Orient Gene Biotech Co., Ltd. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.6.4 Zhejiang Orient Gene Biotech Co., Ltd. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Zhejiang Orient Gene Biotech Co., Ltd. Recent Developments
11.7 HANGZHOU ALLTEST BIOTECH CO., LTD.
11.7.1 HANGZHOU ALLTEST BIOTECH CO., LTD. Corporation Information
11.7.2 HANGZHOU ALLTEST BIOTECH CO., LTD. Business Overview
11.7.3 HANGZHOU ALLTEST BIOTECH CO., LTD. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.7.4 HANGZHOU ALLTEST BIOTECH CO., LTD. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 HANGZHOU ALLTEST BIOTECH CO., LTD. Recent Developments
11.8 R-Biopharm AG
11.8.1 R-Biopharm AG Corporation Information
11.8.2 R-Biopharm AG Business Overview
11.8.3 R-Biopharm AG H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.8.4 R-Biopharm AG H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 R-Biopharm AG Recent Developments
11.9 Denka Company Limited
11.9.1 Denka Company Limited Corporation Information
11.9.2 Denka Company Limited Business Overview
11.9.3 Denka Company Limited H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.9.4 Denka Company Limited H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Denka Company Limited Recent Developments
11.10 Autobio Diagnostics Co., Ltd.
11.10.1 Autobio Diagnostics Co., Ltd. Corporation Information
11.10.2 Autobio Diagnostics Co., Ltd. Business Overview
11.10.3 Autobio Diagnostics Co., Ltd. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.10.4 Autobio Diagnostics Co., Ltd. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Autobio Diagnostics Co., Ltd. Recent Developments
11.11 Getein Biotech, Inc.
11.11.1 Getein Biotech, Inc. Corporation Information
11.11.2 Getein Biotech, Inc. Business Overview
11.11.3 Getein Biotech, Inc. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.11.4 Getein Biotech, Inc. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Getein Biotech, Inc. Recent Developments
11.12 Sentinel Diagnostics
11.12.1 Sentinel Diagnostics Corporation Information
11.12.2 Sentinel Diagnostics Business Overview
11.12.3 Sentinel Diagnostics H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.12.4 Sentinel Diagnostics H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Sentinel Diagnostics Recent Developments
11.13 Boditech Med Inc.
11.13.1 Boditech Med Inc. Corporation Information
11.13.2 Boditech Med Inc. Business Overview
11.13.3 Boditech Med Inc. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.13.4 Boditech Med Inc. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Boditech Med Inc. Recent Developments
11.14 Certest Biotec, S.L.
11.14.1 Certest Biotec, S.L. Corporation Information
11.14.2 Certest Biotec, S.L. Business Overview
11.14.3 Certest Biotec, S.L. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.14.4 Certest Biotec, S.L. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Certest Biotec, S.L. Recent Developments
11.15 MIZUHO MEDY Co., Ltd.
11.15.1 MIZUHO MEDY Co., Ltd. Corporation Information
11.15.2 MIZUHO MEDY Co., Ltd. Business Overview
11.15.3 MIZUHO MEDY Co., Ltd. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.15.4 MIZUHO MEDY Co., Ltd. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 MIZUHO MEDY Co., Ltd. Recent Developments
11.16 Wakamoto Pharmaceutical Co., Ltd.
11.16.1 Wakamoto Pharmaceutical Co., Ltd. Corporation Information
11.16.2 Wakamoto Pharmaceutical Co., Ltd. Business Overview
11.16.3 Wakamoto Pharmaceutical Co., Ltd. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.16.4 Wakamoto Pharmaceutical Co., Ltd. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Wakamoto Pharmaceutical Co., Ltd. Recent Developments
11.17 Humasis Co., Ltd.
11.17.1 Humasis Co., Ltd. Corporation Information
11.17.2 Humasis Co., Ltd. Business Overview
11.17.3 Humasis Co., Ltd. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.17.4 Humasis Co., Ltd. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Humasis Co., Ltd. Recent Developments
11.18 Innovita Biological Technology Co., Ltd.
11.18.1 Innovita Biological Technology Co., Ltd. Corporation Information
11.18.2 Innovita Biological Technology Co., Ltd. Business Overview
11.18.3 Innovita Biological Technology Co., Ltd. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.18.4 Innovita Biological Technology Co., Ltd. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Innovita Biological Technology Co., Ltd. Recent Developments
11.19 Assure Tech Hangzhou Co., Ltd.
11.19.1 Assure Tech Hangzhou Co., Ltd. Corporation Information
11.19.2 Assure Tech Hangzhou Co., Ltd. Business Overview
11.19.3 Assure Tech Hangzhou Co., Ltd. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.19.4 Assure Tech Hangzhou Co., Ltd. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Assure Tech Hangzhou Co., Ltd. Recent Developments
11.20 Trinity Biotech plc
11.20.1 Trinity Biotech plc Corporation Information
11.20.2 Trinity Biotech plc Business Overview
11.20.3 Trinity Biotech plc H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.20.4 Trinity Biotech plc H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Trinity Biotech plc Recent Developments
11.21 Savyon Diagnostics Ltd.
11.21.1 Savyon Diagnostics Ltd. Corporation Information
11.21.2 Savyon Diagnostics Ltd. Business Overview
11.21.3 Savyon Diagnostics Ltd. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.21.4 Savyon Diagnostics Ltd. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Savyon Diagnostics Ltd. Recent Developments
11.22 nal von minden GmbH
11.22.1 nal von minden GmbH Corporation Information
11.22.2 nal von minden GmbH Business Overview
11.22.3 nal von minden GmbH H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.22.4 nal von minden GmbH H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 nal von minden GmbH Recent Developments
11.23 DIALAB GmbH
11.23.1 DIALAB GmbH Corporation Information
11.23.2 DIALAB GmbH Business Overview
11.23.3 DIALAB GmbH H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.23.4 DIALAB GmbH H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 DIALAB GmbH Recent Developments
11.24 Biopanda Reagents Ltd.
11.24.1 Biopanda Reagents Ltd. Corporation Information
11.24.2 Biopanda Reagents Ltd. Business Overview
11.24.3 Biopanda Reagents Ltd. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.24.4 Biopanda Reagents Ltd. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 Biopanda Reagents Ltd. Recent Developments
11.25 Apacor Limited
11.25.1 Apacor Limited Corporation Information
11.25.2 Apacor Limited Business Overview
11.25.3 Apacor Limited H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.25.4 Apacor Limited H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 Apacor Limited Recent Developments
11.26 Panion & BF Biotech, Inc.
11.26.1 Panion & BF Biotech, Inc. Corporation Information
11.26.2 Panion & BF Biotech, Inc. Business Overview
11.26.3 Panion & BF Biotech, Inc. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.26.4 Panion & BF Biotech, Inc. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.26.5 Panion & BF Biotech, Inc. Recent Developments
11.27 STRONG BIOTECH CORPORATION
11.27.1 STRONG BIOTECH CORPORATION Corporation Information
11.27.2 STRONG BIOTECH CORPORATION Business Overview
11.27.3 STRONG BIOTECH CORPORATION H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.27.4 STRONG BIOTECH CORPORATION H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.27.5 STRONG BIOTECH CORPORATION Recent Developments
11.28 Beijing Lepu Diagnostics Technology Co., Ltd.
11.28.1 Beijing Lepu Diagnostics Technology Co., Ltd. Corporation Information
11.28.2 Beijing Lepu Diagnostics Technology Co., Ltd. Business Overview
11.28.3 Beijing Lepu Diagnostics Technology Co., Ltd. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.28.4 Beijing Lepu Diagnostics Technology Co., Ltd. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.28.5 Beijing Lepu Diagnostics Technology Co., Ltd. Recent Developments
11.29 Cofoe Medical Technology Co., Ltd.
11.29.1 Cofoe Medical Technology Co., Ltd. Corporation Information
11.29.2 Cofoe Medical Technology Co., Ltd. Business Overview
11.29.3 Cofoe Medical Technology Co., Ltd. H. pylori Stool Antigen Tests Product Models, Descriptions and Specifications
11.29.4 Cofoe Medical Technology Co., Ltd. H. pylori Stool Antigen Tests Sales, Price, Revenue and Gross Margin (2021-2026)
11.29.5 Cofoe Medical Technology Co., Ltd. Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 H. pylori Stool Antigen Tests Industry Chain
12.2 H. pylori Stool Antigen Tests Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 H. pylori Stool Antigen Tests Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 H. pylori Stool Antigen Tests Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 H. pylori Stool Antigen Tests Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global H. pylori Stool Antigen Tests Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global H. pylori Stool Antigen Tests Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global H. pylori Stool Antigen Tests Market Size Growth Rate by Operating Format, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global H. pylori Stool Antigen Tests Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global H. pylori Stool Antigen Tests Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global H. pylori Stool Antigen Tests Revenue by Region (US$ Million), 2021-2026
Table 6. Global H. pylori Stool Antigen Tests Revenue by Region (US$ Million), 2027-2032
Table 7. Global H. pylori Stool Antigen Tests Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (Units)
Table 8. Global H. pylori Stool Antigen Tests Sales by Region (Units), 2021-2026
Table 9. Global H. pylori Stool Antigen Tests Sales by Region (Units), 2027-2032
Table 10. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 11. Global H. pylori Stool Antigen Tests Sales by Manufacturers (Units), 2021-2026
Table 12. Global H. pylori Stool Antigen Tests Sales Share by Manufacturers (2021-2026)
Table 13. Global H. pylori Stool Antigen Tests Revenue by Manufacturers (US$ Million), 2021-2026
Table 14. Global H. pylori Stool Antigen Tests Revenue-Based Market Share by Manufacturers (2021-2026)
Table 15. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 16. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on H. pylori Stool Antigen Tests Revenue, 2025
Table 17. Global H. pylori Stool Antigen Tests Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 18. Global H. pylori Stool Antigen Tests Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 19. Key Manufacturers H. pylori Stool Antigen Tests Manufacturing Base and Headquarters
Table 20. Global H. pylori Stool Antigen Tests Market Concentration Ratio (CR5)
Table 21. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 22. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 23. Global H. pylori Stool Antigen Tests Sales Volume by Type (Units), 2021-2026
Table 24. Global H. pylori Stool Antigen Tests Sales Volume by Type (Units), 2027-2032
Table 25. Global H. pylori Stool Antigen Tests Revenue by Type (US$ Million), 2021-2026
Table 26. Global H. pylori Stool Antigen Tests Revenue by Type (US$ Million), 2027-2032
Table 27. Global H. pylori Stool Antigen Tests Sales Volume by Operating Format (Units), 2021-2026
Table 28. Global H. pylori Stool Antigen Tests Sales Volume by Operating Format (Units), 2027-2032
Table 29. Global H. pylori Stool Antigen Tests Revenue by Operating Format (US$ Million), 2021-2026
Table 30. Global H. pylori Stool Antigen Tests Revenue by Operating Format (US$ Million), 2027-2032
Table 31. Technical Specifications by Key Product Type
Table 32. Global H. pylori Stool Antigen Tests Sales by Application (Units), 2021-2026
Table 33. Global H. pylori Stool Antigen Tests Sales by Application (Units), 2027-2032
Table 34. H. pylori Stool Antigen Tests High-Growth Sectors Demand CAGR (2026-2032)
Table 35. Global H. pylori Stool Antigen Tests Revenue by Application (US$ Million), 2021-2026
Table 36. Global H. pylori Stool Antigen Tests Revenue by Application (US$ Million), 2027-2032
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America H. pylori Stool Antigen Tests Growth Accelerators and Market Barriers
Table 40. North America H. pylori Stool Antigen Tests Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 41. North America H. pylori Stool Antigen Tests Sales (Units) by Country (2021 vs 2025 vs 2032)
Table 42. Europe H. pylori Stool Antigen Tests Growth Accelerators and Market Barriers
Table 43. Europe H. pylori Stool Antigen Tests Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Europe H. pylori Stool Antigen Tests Sales (Units) by Country (2021 vs 2025 vs 2032)
Table 45. Asia-Pacific H. pylori Stool Antigen Tests Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Asia-Pacific H. pylori Stool Antigen Tests Sales (Units) by Country (2021 vs 2025 vs 2032)
Table 47. Asia-Pacific H. pylori Stool Antigen Tests Growth Accelerators and Market Barriers
Table 48. Southeast Asia H. pylori Stool Antigen Tests Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Central and South America H. pylori Stool Antigen Tests Investment Opportunities and Key Challenges
Table 50. Central and South America H. pylori Stool Antigen Tests Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 51. Middle East and Africa H. pylori Stool Antigen Tests Investment Opportunities and Key Challenges
Table 52. Middle East and Africa H. pylori Stool Antigen Tests Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 53. Abbott Laboratories Corporation Information
Table 54. Abbott Laboratories Description and Major Businesses
Table 55. Abbott Laboratories Product Models, Descriptions and Specifications
Table 56. Abbott Laboratories Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 57. Abbott Laboratories Sales Value Proportion by Product in 2025
Table 58. Abbott Laboratories Sales Value Proportion by Application in 2025
Table 59. Abbott Laboratories Sales Value Proportion by Geographic Area in 2025
Table 60. Abbott Laboratories H. pylori Stool Antigen Tests SWOT Analysis
Table 61. Abbott Laboratories Recent Developments
Table 62. SD Biosensor, Inc. Corporation Information
Table 63. SD Biosensor, Inc. Description and Major Businesses
Table 64. SD Biosensor, Inc. Product Models, Descriptions and Specifications
Table 65. SD Biosensor, Inc. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. SD Biosensor, Inc. Sales Value Proportion by Product in 2025
Table 67. SD Biosensor, Inc. Sales Value Proportion by Application in 2025
Table 68. SD Biosensor, Inc. Sales Value Proportion by Geographic Area in 2025
Table 69. SD Biosensor, Inc. H. pylori Stool Antigen Tests SWOT Analysis
Table 70. SD Biosensor, Inc. Recent Developments
Table 71. SSI Diagnostica A/S Corporation Information
Table 72. SSI Diagnostica A/S Description and Major Businesses
Table 73. SSI Diagnostica A/S Product Models, Descriptions and Specifications
Table 74. SSI Diagnostica A/S Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. SSI Diagnostica A/S Sales Value Proportion by Product in 2025
Table 76. SSI Diagnostica A/S Sales Value Proportion by Application in 2025
Table 77. SSI Diagnostica A/S Sales Value Proportion by Geographic Area in 2025
Table 78. SSI Diagnostica A/S H. pylori Stool Antigen Tests SWOT Analysis
Table 79. SSI Diagnostica A/S Recent Developments
Table 80. ACON Laboratories, Inc. Corporation Information
Table 81. ACON Laboratories, Inc. Description and Major Businesses
Table 82. ACON Laboratories, Inc. Product Models, Descriptions and Specifications
Table 83. ACON Laboratories, Inc. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. ACON Laboratories, Inc. Sales Value Proportion by Product in 2025
Table 85. ACON Laboratories, Inc. Sales Value Proportion by Application in 2025
Table 86. ACON Laboratories, Inc. Sales Value Proportion by Geographic Area in 2025
Table 87. ACON Laboratories, Inc. H. pylori Stool Antigen Tests SWOT Analysis
Table 88. ACON Laboratories, Inc. Recent Developments
Table 89. Guangzhou Wondfo Biotech Co., Ltd. Corporation Information
Table 90. Guangzhou Wondfo Biotech Co., Ltd. Description and Major Businesses
Table 91. Guangzhou Wondfo Biotech Co., Ltd. Product Models, Descriptions and Specifications
Table 92. Guangzhou Wondfo Biotech Co., Ltd. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Guangzhou Wondfo Biotech Co., Ltd. Sales Value Proportion by Product in 2025
Table 94. Guangzhou Wondfo Biotech Co., Ltd. Sales Value Proportion by Application in 2025
Table 95. Guangzhou Wondfo Biotech Co., Ltd. Sales Value Proportion by Geographic Area in 2025
Table 96. Guangzhou Wondfo Biotech Co., Ltd. H. pylori Stool Antigen Tests SWOT Analysis
Table 97. Guangzhou Wondfo Biotech Co., Ltd. Recent Developments
Table 98. Zhejiang Orient Gene Biotech Co., Ltd. Corporation Information
Table 99. Zhejiang Orient Gene Biotech Co., Ltd. Description and Major Businesses
Table 100. Zhejiang Orient Gene Biotech Co., Ltd. Product Models, Descriptions and Specifications
Table 101. Zhejiang Orient Gene Biotech Co., Ltd. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Zhejiang Orient Gene Biotech Co., Ltd. Recent Developments
Table 103. HANGZHOU ALLTEST BIOTECH CO., LTD. Corporation Information
Table 104. HANGZHOU ALLTEST BIOTECH CO., LTD. Description and Major Businesses
Table 105. HANGZHOU ALLTEST BIOTECH CO., LTD. Product Models, Descriptions and Specifications
Table 106. HANGZHOU ALLTEST BIOTECH CO., LTD. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. HANGZHOU ALLTEST BIOTECH CO., LTD. Recent Developments
Table 108. R-Biopharm AG Corporation Information
Table 109. R-Biopharm AG Description and Major Businesses
Table 110. R-Biopharm AG Product Models, Descriptions and Specifications
Table 111. R-Biopharm AG Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. R-Biopharm AG Recent Developments
Table 113. Denka Company Limited Corporation Information
Table 114. Denka Company Limited Description and Major Businesses
Table 115. Denka Company Limited Product Models, Descriptions and Specifications
Table 116. Denka Company Limited Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Denka Company Limited Recent Developments
Table 118. Autobio Diagnostics Co., Ltd. Corporation Information
Table 119. Autobio Diagnostics Co., Ltd. Description and Major Businesses
Table 120. Autobio Diagnostics Co., Ltd. Product Models, Descriptions and Specifications
Table 121. Autobio Diagnostics Co., Ltd. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Autobio Diagnostics Co., Ltd. Recent Developments
Table 123. Getein Biotech, Inc. Corporation Information
Table 124. Getein Biotech, Inc. Description and Major Businesses
Table 125. Getein Biotech, Inc. Product Models, Descriptions and Specifications
Table 126. Getein Biotech, Inc. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Getein Biotech, Inc. Recent Developments
Table 128. Sentinel Diagnostics Corporation Information
Table 129. Sentinel Diagnostics Description and Major Businesses
Table 130. Sentinel Diagnostics Product Models, Descriptions and Specifications
Table 131. Sentinel Diagnostics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Sentinel Diagnostics Recent Developments
Table 133. Boditech Med Inc. Corporation Information
Table 134. Boditech Med Inc. Description and Major Businesses
Table 135. Boditech Med Inc. Product Models, Descriptions and Specifications
Table 136. Boditech Med Inc. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Boditech Med Inc. Recent Developments
Table 138. Certest Biotec, S.L. Corporation Information
Table 139. Certest Biotec, S.L. Description and Major Businesses
Table 140. Certest Biotec, S.L. Product Models, Descriptions and Specifications
Table 141. Certest Biotec, S.L. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Certest Biotec, S.L. Recent Developments
Table 143. MIZUHO MEDY Co., Ltd. Corporation Information
Table 144. MIZUHO MEDY Co., Ltd. Description and Major Businesses
Table 145. MIZUHO MEDY Co., Ltd. Product Models, Descriptions and Specifications
Table 146. MIZUHO MEDY Co., Ltd. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. MIZUHO MEDY Co., Ltd. Recent Developments
Table 148. Wakamoto Pharmaceutical Co., Ltd. Corporation Information
Table 149. Wakamoto Pharmaceutical Co., Ltd. Description and Major Businesses
Table 150. Wakamoto Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 151. Wakamoto Pharmaceutical Co., Ltd. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Wakamoto Pharmaceutical Co., Ltd. Recent Developments
Table 153. Humasis Co., Ltd. Corporation Information
Table 154. Humasis Co., Ltd. Description and Major Businesses
Table 155. Humasis Co., Ltd. Product Models, Descriptions and Specifications
Table 156. Humasis Co., Ltd. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Humasis Co., Ltd. Recent Developments
Table 158. Innovita Biological Technology Co., Ltd. Corporation Information
Table 159. Innovita Biological Technology Co., Ltd. Description and Major Businesses
Table 160. Innovita Biological Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 161. Innovita Biological Technology Co., Ltd. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Innovita Biological Technology Co., Ltd. Recent Developments
Table 163. Assure Tech Hangzhou Co., Ltd. Corporation Information
Table 164. Assure Tech Hangzhou Co., Ltd. Description and Major Businesses
Table 165. Assure Tech Hangzhou Co., Ltd. Product Models, Descriptions and Specifications
Table 166. Assure Tech Hangzhou Co., Ltd. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Assure Tech Hangzhou Co., Ltd. Recent Developments
Table 168. Trinity Biotech plc Corporation Information
Table 169. Trinity Biotech plc Description and Major Businesses
Table 170. Trinity Biotech plc Product Models, Descriptions and Specifications
Table 171. Trinity Biotech plc Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Trinity Biotech plc Recent Developments
Table 173. Savyon Diagnostics Ltd. Corporation Information
Table 174. Savyon Diagnostics Ltd. Description and Major Businesses
Table 175. Savyon Diagnostics Ltd. Product Models, Descriptions and Specifications
Table 176. Savyon Diagnostics Ltd. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Savyon Diagnostics Ltd. Recent Developments
Table 178. nal von minden GmbH Corporation Information
Table 179. nal von minden GmbH Description and Major Businesses
Table 180. nal von minden GmbH Product Models, Descriptions and Specifications
Table 181. nal von minden GmbH Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. nal von minden GmbH Recent Developments
Table 183. DIALAB GmbH Corporation Information
Table 184. DIALAB GmbH Description and Major Businesses
Table 185. DIALAB GmbH Product Models, Descriptions and Specifications
Table 186. DIALAB GmbH Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. DIALAB GmbH Recent Developments
Table 188. Biopanda Reagents Ltd. Corporation Information
Table 189. Biopanda Reagents Ltd. Description and Major Businesses
Table 190. Biopanda Reagents Ltd. Product Models, Descriptions and Specifications
Table 191. Biopanda Reagents Ltd. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Biopanda Reagents Ltd. Recent Developments
Table 193. Apacor Limited Corporation Information
Table 194. Apacor Limited Description and Major Businesses
Table 195. Apacor Limited Product Models, Descriptions and Specifications
Table 196. Apacor Limited Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. Apacor Limited Recent Developments
Table 198. Panion & BF Biotech, Inc. Corporation Information
Table 199. Panion & BF Biotech, Inc. Description and Major Businesses
Table 200. Panion & BF Biotech, Inc. Product Models, Descriptions and Specifications
Table 201. Panion & BF Biotech, Inc. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. Panion & BF Biotech, Inc. Recent Developments
Table 203. STRONG BIOTECH CORPORATION Corporation Information
Table 204. STRONG BIOTECH CORPORATION Description and Major Businesses
Table 205. STRONG BIOTECH CORPORATION Product Models, Descriptions and Specifications
Table 206. STRONG BIOTECH CORPORATION Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. STRONG BIOTECH CORPORATION Recent Developments
Table 208. Beijing Lepu Diagnostics Technology Co., Ltd. Corporation Information
Table 209. Beijing Lepu Diagnostics Technology Co., Ltd. Description and Major Businesses
Table 210. Beijing Lepu Diagnostics Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 211. Beijing Lepu Diagnostics Technology Co., Ltd. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 212. Beijing Lepu Diagnostics Technology Co., Ltd. Recent Developments
Table 213. Cofoe Medical Technology Co., Ltd. Corporation Information
Table 214. Cofoe Medical Technology Co., Ltd. Description and Major Businesses
Table 215. Cofoe Medical Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 216. Cofoe Medical Technology Co., Ltd. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 217. Cofoe Medical Technology Co., Ltd. Recent Developments
Table 218. Key Raw Materials Distribution
Table 219. Raw Materials Key Suppliers
Table 220. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 221. Milestones in Production Technology Evolution
Table 222. Distributors List
Table 223. Market Trends and Market Evolution
Table 224. Market Drivers and Opportunities
Table 225. Market Challenges, Risks, and Restraints
Table 226. Research Programs/Design for This Report
Table 227. Key Data Information from Secondary Sources
Table 228. Key Data Information from Primary Sources

List of Figures
Figure 1. H. pylori Stool Antigen Tests Product Picture
Figure 2. Global H. pylori Stool Antigen Tests Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Lateral Flow Immunochromatography Product Picture
Figure 4. Fluorescence Immunoassay Product Picture
Figure 5. Enzyme Immunoassay Product Picture
Figure 6. Chemiluminescence Immunoassay Product Picture
Figure 7. Latex Turbidimetric Immunoassay Product Picture
Figure 8. Other Product Picture
Figure 9. Global H. pylori Stool Antigen Tests Market Size Growth Rate by Operating Format, 2021 vs 2025 vs 2032 (US$ Million)
Figure 10. Visual Cassette Product Picture
Figure 11. Reader Assisted Cassette Product Picture
Figure 12. Microplate Kit Product Picture
Figure 13. Automated Analyzer Reagent Product Picture
Figure 14. Other Product Picture
Figure 15. Global H. pylori Stool Antigen Tests Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 16. Home Self-Testing
Figure 17. Primary Care Clinic Testing
Figure 18. Gastroenterology Clinic Testing
Figure 19. Hospital Point-of-Care Testing
Figure 20. Hospital Central Laboratory Testing
Figure 21. Independent Reference Laboratory Testing
Figure 22. Other
Figure 23. H. pylori Stool Antigen Tests Report Years Considered
Figure 24. Global H. pylori Stool Antigen Tests Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 26. Global H. pylori Stool Antigen Tests Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 27. Global H. pylori Stool Antigen Tests Revenue-Based Market Share by Region (2021-2032)
Figure 28. Global H. pylori Stool Antigen Tests Sales (Units), 2021-2032
Figure 29. Global H. pylori Stool Antigen Tests Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (Units)
Figure 30. Global H. pylori Stool Antigen Tests Sales Market Share by Region (2021-2032)
Figure 31. Top 5 and Top 10 Manufacturers H. pylori Stool Antigen Tests Sales Volume Market Share in 2025
Figure 32. Global H. pylori Stool Antigen Tests Revenue-Based Market Share Ranking (2025)
Figure 33. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 34. Lateral Flow Immunochromatography Revenue-Based Market Share by Manufacturer in 2025
Figure 35. Fluorescence Immunoassay Revenue-Based Market Share by Manufacturer in 2025
Figure 36. Enzyme Immunoassay Revenue-Based Market Share by Manufacturer in 2025
Figure 37. Chemiluminescence Immunoassay Revenue-Based Market Share by Manufacturer in 2025
Figure 38. Latex Turbidimetric Immunoassay Revenue-Based Market Share by Manufacturer in 2025
Figure 39. Other Revenue-Based Market Share by Manufacturer in 2025
Figure 40. Global H. pylori Stool Antigen Tests Sales Volume-Based Market Share by Type (2021-2032)
Figure 41. Global H. pylori Stool Antigen Tests Revenue-Based Market Share by Type (2021-2032)
Figure 42. Global H. pylori Stool Antigen Tests ASP by Type (US$/Unit), 2021-2032
Figure 43. Global H. pylori Stool Antigen Tests Sales Volume-Based Market Share by Operating Format (2021-2032)
Figure 44. Global H. pylori Stool Antigen Tests Revenue-Based Market Share by Operating Format (2021-2032)
Figure 45. Global H. pylori Stool Antigen Tests ASP by Operating Format (US$/Unit), 2021-2032
Figure 46. Global H. pylori Stool Antigen Tests Revenue-Based Market Share (2021-2032)
Figure 47. Global H. pylori Stool Antigen Tests Sales Market Share by Application (2021-2032)
Figure 48. Global H. pylori Stool Antigen Tests Revenue-Based Market Share by Application (2021-2032)
Figure 49. Global H. pylori Stool Antigen Tests ASP by Application (US$/Unit), 2021-2032
Figure 50. North America H. pylori Stool Antigen Tests Sales YoY (Units), 2021-2032
Figure 51. North America H. pylori Stool Antigen Tests Revenue YoY (US$ Million), 2021-2032
Figure 52. North America Top 5 Manufacturers H. pylori Stool Antigen Tests Sales Revenue (US$ Million) in 2025
Figure 53. North America H. pylori Stool Antigen Tests Sales Volume (Units) by Application (2021-2032)
Figure 54. North America H. pylori Stool Antigen Tests Sales Revenue (US$ Million) by Application (2021-2032)
Figure 55. US H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 56. Canada H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 57. Mexico H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 58. Europe H. pylori Stool Antigen Tests Sales YoY (Units), 2021-2032
Figure 59. Europe H. pylori Stool Antigen Tests Revenue YoY (US$ Million), 2021-2032
Figure 60. Europe Top 5 Manufacturers H. pylori Stool Antigen Tests Sales Revenue (US$ Million) in 2025
Figure 61. Europe H. pylori Stool Antigen Tests Sales Volume (Units) by Application (2021-2032)
Figure 62. Europe H. pylori Stool Antigen Tests Sales Revenue (US$ Million) by Application (2021-2032)
Figure 63. Germany H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 64. France H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 65. U.K. H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 66. Italy H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 67. Russia H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 68. Asia-Pacific H. pylori Stool Antigen Tests Sales YoY (Units), 2021-2032
Figure 69. Asia-Pacific H. pylori Stool Antigen Tests Revenue YoY (US$ Million), 2021-2032
Figure 70. Asia-Pacific Top 8 Manufacturers H. pylori Stool Antigen Tests Sales Revenue (US$ Million) in 2025
Figure 71. Asia-Pacific H. pylori Stool Antigen Tests Sales Volume (Units) by Application (2021-2032)
Figure 72. Asia-Pacific H. pylori Stool Antigen Tests Sales Revenue (US$ Million) by Application (2021-2032)
Figure 73. Indonesia H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 74. Japan H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 75. South Korea H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 76. China Taiwan H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 77. India H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 78. Central and South America H. pylori Stool Antigen Tests Sales YoY (Units), 2021-2032
Figure 79. Central and South America H. pylori Stool Antigen Tests Revenue YoY (US$ Million), 2021-2032
Figure 80. Central and South America Top 5 Manufacturers H. pylori Stool Antigen Tests Sales Revenue (US$ Million) in 2025
Figure 81. Central and South America H. pylori Stool Antigen Tests Sales Volume (Units) by Application (2021-2032)
Figure 82. Central and South America H. pylori Stool Antigen Tests Sales Revenue (US$ Million) by Application (2021-2032)
Figure 83. Brazil H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 84. Argentina H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 85. Middle East, and Africa H. pylori Stool Antigen Tests Sales YoY (Units), 2021-2032
Figure 86. Middle East and Africa H. pylori Stool Antigen Tests Revenue YoY (US$ Million), 2021-2032
Figure 87. Middle East and Africa Top 5 Manufacturers H. pylori Stool Antigen Tests Sales Revenue (US$ Million) in 2025
Figure 88. Middle East and Africa H. pylori Stool Antigen Tests Sales Volume (Units) by Application (2021-2032)
Figure 89. Middle East and Africa H. pylori Stool Antigen Tests Sales Revenue (US$ Million) by Application (2021-2032)
Figure 90. GCC Countries H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 91. Turkey H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 92. Egypt H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 93. South Africa H. pylori Stool Antigen Tests Revenue (US$ Million), 2021-2032
Figure 94. H. pylori Stool Antigen Tests Industry Chain Mapping
Figure 95. Regional H. pylori Stool Antigen Tests Manufacturing Base Distribution (%)
Figure 96. Global H. pylori Stool Antigen Tests Production Market Share by Region (2021-2032)
Figure 97. H. pylori Stool Antigen Tests Production Process
Figure 98. Regional H. pylori Stool Antigen Tests Production Cost Structure
Figure 99. Channels of Distribution (Direct Vs Distribution)
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed